Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Asset Utilization Ratio: 2012-2025

Historic Asset Utilization Ratio for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to 0.52.

  • Lifecore Biomedical's Asset Utilization Ratio rose 5.35% to 0.54 in Q2 2025 from the same period last year, while for May 2025 it was 0.54, marking a year-over-year increase of 5.35%. This contributed to the annual value of 0.52 for FY2025, which is 3.37% up from last year.
  • Per Lifecore Biomedical's latest filing, its Asset Utilization Ratio stood at 0.52 for FY2025, which was up 3.37% from 0.51 recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Asset Utilization Ratio registered a high of 0.52 during FY2025, and its lowest value of 0.25 during FY2021.
  • For the 3-year period, Lifecore Biomedical's Asset Utilization Ratio averaged around 0.47, with its median value being 0.51 (2024).
  • As far as peak fluctuations go, Lifecore Biomedical's Asset Utilization Ratio plummeted by 35.62% in 2021, and later skyrocketed by 36.44% in 2023.
  • Over the past 5 years, Lifecore Biomedical's Asset Utilization Ratio (Yearly) stood at 0.25 in 2021, then climbed by 12.98% to 0.29 in 2022, then skyrocketed by 36.44% to 0.39 in 2023, then rose by 29.28% to 0.51 in 2024, then increased by 3.37% to 0.52 in 2025.